WELCOME!
About Pharmazac
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Fusce convallis nulla libero, ut laoreet tortor scelerisque sed. Sed ullamcorper leo arcu, a faucibus massa tristique a. Duis id sapien eget nisi commodo scelerisque.Lorem ipsum dolor sit amet, consectetur adipiscing elit. Fusce convallis nulla libero, ut laoreet tortor scelerisque sed. Sed ullamcorper leo arcu, a faucibus massa tristique a. Duis id sapien eget nisi commodo scelerisque.Lorem ipsum dolor sit amet, consectetur adipiscing elit. Fusce convallis nulla libero, ut laoreet tortor scelerisque sed. Sed ullamcorper leo arcu, a faucibus massa tristique a. Duis id sapien eget nisi commodo scelerisque.Lorem ipsum dolor sit amet, consectetur adipiscing elit.
CAPACITY
Today we count
40 years of history
40 years of history
40 years of history
40 years of history
DISCOVER
What we do
Pharmaceuticals
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum is simply dummy text of the printing and typesetting industry.
Diagnostics & Radiopharmaceutical
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum is simply dummy text of the printing and typesetting industry.
Future Research Pipeline
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum is simply dummy text of the printing and typesetting industry.
PHARMAZAC
Recent Launches
MELIGLIX F.C.TAB 100MG/TAB BT x 28 TABS MELIGLIX F.C.TAB 50MG/TAB BT x 28 TABS MELIGLIX F.C.TAB 25MG/TAB BT x 28 TABS
| MELIGLIX F.C.TAB 100MG/TAB BT x 28 TABS |
| MELIGLIX F.C.TAB 50MG/TAB BT x 28 TABS |
| MELIGLIX F.C.TAB 25MG/TAB BT x 28 TABS |
LURASIDONE/PHARMAZAC F.C.TAB 37MG/TAB BT x 28 LURASIDONE/PHARMAZAC F.C.TAB 74MG/TAB BT x 28
| LURASIDONE/PHARMAZAC F.C.TAB 37MG/TAB BT x 28 |
| LURASIDONE/PHARMAZAC F.C.TAB 74MG/TAB BT x 28 |
HEDIMAL NASPR.SOL 100MG/ML BT x 1 VIAL x 1.8ML
| HEDIMAL NASPR.SOL 100MG/ML BT x 1 VIAL x 1.8ML |
EVEROLIMUS/PHARMAZAC TABLET 5MG/TAB BTx30 EVEROLIMUS/PHARMAZAC TABLET 10MG/TAB BTx30
| EVEROLIMUS/PHARMAZAC TABLET 5MG/TAB BTx30 |
| EVEROLIMUS/PHARMAZAC TABLET 10MG/TAB BTx30 |
DULSEVIA GR.CAP 30MG/CAP BTx30 CAPS DULSEVIA GR.CAP 60MG/CAP BTx30 CAPS
| DULSEVIA GR.CAP 30MG/CAP BTx30 CAPS |
| DULSEVIA GR.CAP 60MG/CAP BTx30 CAPS |
CALCIFOLIN TABLET 15MG/TAB BTx10 CALCIFOLIN TABLET 25MG/TAB BTx10
| CALCIFOLIN TABLET 15MG/TAB BTx10 |
| CALCIFOLIN TABLET 25MG/TAB BTx10 |
BRIVARACETAM/PHARMAZAC F.C.TAB 10MG/TAB BTx14 BRIVARACETAM/PHARMAZAC F.C.TAB 25MG/TAB BTx56 BRIVARACETAM/PHARMAZAC F.C.TAB 50MG/TAB BTx56 BRIVARACETAM/PHARMAZAC F.C.TAB 75MG/TAB BTx56 BRIVARACETAM/PHARMAZAC F.C.TAB 100MG/TAB BTx56
| BRIVARACETAM/PHARMAZAC F.C.TAB 10MG/TAB BTx14 |
| BRIVARACETAM/PHARMAZAC F.C.TAB 25MG/TAB BTx56 |
| BRIVARACETAM/PHARMAZAC F.C.TAB 50MG/TAB BTx56 |
| BRIVARACETAM/PHARMAZAC F.C.TAB 75MG/TAB BTx56 |
| BRIVARACETAM/PHARMAZAC F.C.TAB 100MG/TAB BTx56 |
Partnerships
Latest News
PharmaZac sponsors the medical book “Epilepsy and Movement Disorders” of Dr. A. Alexoudi Neurologist Ph.D of National and Kapodistrian University of Athens and Dr. S. Gatzonis, […]
Pharmazac launched the new product Cinacalcet 30-60 and 90mg in F.C.Tablets. Cinacalcet indicated for the treatment of secondary Hyperparathyroidism (HPT) in adult patients with chronic kidney […]
We are welcoming KRKA in Greece and we are supporting them as their distributor! Pharmazac iw happy to announce that it will begin in December ΄20 […]
We are becoming a manufacturer and key player in radiopharmaceuticals ! Pharmazac is happy to announce that its radiopharmaceuticals manufacturing unit in the industrial zone of […]
With Covid-19 on the way of most of our exhibiting activities, Pharmazac has joined in 2020 the largest pharmaceutical partnering events and has participated in more […]
Pharmazac launched the new product Zaolin/Vinorelbin the first generic version for oral use ( soft gelatin caps) in Greece. Zaolin/Vinorelbin is a chemotherapy drug used to […]
Pharmazac is working on its latest investment a new site of 10.000 sq.m for pharmaceuticals manufacturing, in the industrial zone of Keratea near Athens area . […]
Pharmazac launched Etrozac / etoricoxib a selective cyclo-oxygenase – 2 (COX-2) inhibitor. Etrozac indicated for the treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute pain and […]
Pharmazac S.A participates in the online CPhI festival of pharma 2020
Accreditations
